Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2018-003106-29-FR
EUCTR2018-003106-29-FR
Active, not recruiting
Phase 1

Feasibility and efficacy of a new ovarian stimulation regimen with RANDom start, use of corifollitropin alpha and progestin protocol for Oocyte donorS - RANDOS

CHI Créteil0 sites110 target enrollmentSeptember 25, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsinfertilityMedDRA version: 20.0Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersTherapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]
DrugsDESOGESTREL

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
infertility
Sponsor
CHI Créteil
Enrollment
110
Status
Active, not recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 25, 2018
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
CHI Créteil

Eligibility Criteria

Inclusion Criteria

  • •\- Donor of oocytes having spontaneous and regular menstrual cycles, and having taken no hormonal treatment (in particular contraceptive) during the cycle preceding the donation.
  • •\- Patient with normal ovarian reserve with antral follicle count\> 8,
  • •\- BMI between 18 and 32
  • •\- Regular natural menstrual cycles, and absence of hormonal treatment during the cycle preceding the donation cycle
  • •\- Major patient
  • •\- Affiliation to social security
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 110

Exclusion Criteria

  • •\- Stage 3\-4 endometriosis
  • •\- ovarian cyst\> 30 mm,
  • •\- Polycystic ovary syndrome
  • •\- Patient under tutorship or curatorship

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study of the effects of a novel ovarian stimulation regimen on embryo aneuploidy rates in IVF, and the impact of aneuploidy on implantation, as assessed in an in vitro model.10013356embryo aneuploidy1008362410000211
NL-OMON33651niversitair Medisch Centrum Utrecht110
Recruiting
Phase 3
We propose a new controlled ovarian hyperstimulation (COH) protocol for polycystic ovary syndrome (PCOS).Polycystic ovary syndrome(PCOS)
JPRN-UMIN000045214Saint Mother Clinic50
Recruiting
Not Applicable
Easier and less expensive ovarian stimulation for women at high risk for ovarian hyperstimulation: a randomized controlled trialFemale Infertilityrisk of ovarian hyperstimulationC13.351.500.365.700C13.351.500.056.630.642
RBR-736jwhFaculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Completed
Phase 3
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte DonorsInfertility
NCT03895099Centre Hospitalier Intercommunal Creteil110
Completed
Not Applicable
effect of ovarian stimulation drugs on incidance of unruptured follicleCondition 1: luteinized unruptured follicle. Condition 2: luteinized unruptured follicle.Female infertility associated with anovulationFemale infertility, unspecified
IRCT2014091019113N1Tehran University Of Medical Sciences180